Search research articles
Contact Us
Filters
Showing results (381-390 of 406) with videos related to
Page
of 41
Sort By:
Breast Cancer Research and Treatment
|
March 13, 2019
Clinical outcomes of breast leptomeningeal disease treated with intrathecal trastuzumab, intrathecal chemotherapy, or whole brain radiation therapy
Nicholas B Figura, Victoria T Rizk, Homan Mohammadi, et al.
International Journal of Molecular Sciences
|
May 7, 2025
Intravenous Immunoglobulin (IVIG) for Patients with Severe Neurotoxicity Associated with Chimeric Antigen Receptor T-Cell (CAR-T) Therapy
Sepideh Mokhtari, Justin M Asquith, Syeda Saba Kareem, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 26, 2021
Single-Cell Characterization of the Immune Microenvironment of Melanoma Brain and Leptomeningeal Metastases
Inna Smalley, Zhihua Chen, Manali Phadke, et al.
Neuro-Oncology
|
February 25, 2022
A preclinical model of patient-derived cerebrospinal fluid circulating tumor cells for experimental therapeutics in leptomeningeal disease from melanoma
Vincent Law, Zhihua Chen, Francesca Vena, et al.
Veterinary Pathology
|
May 5, 2006
The 2000 canine distemper epidemic in Caspian seals (Phoca caspica): pathology and analysis of contributory factors
T Kuiken, S Kennedy, T Barrett, et al.
BMC Cancer
|
May 16, 2021
Capecitabine and stereotactic radiation in the management of breast cancer brain metastases
Matthew N Mills, Afrin Naz, Chetna Thawani, et al.
Neuro-Oncology
|
April 16, 2013
Treating brain tumor-initiating cells using a combination of myxoma virus and rapamycin
Franz J Zemp, Xueqing Lun, Brienne A McKenzie, et al.
Cancer Immunology Research
|
November 17, 2021
Identification of Immunogenic MHC Class II Human HER3 Peptides that Mediate Anti-HER3 CD4<sup>+</sup> Th1 Responses and Potential Use as a Cancer Vaccine
Amrita Basu, Gabriella K Albert, Sabrina Awshah, et al.
Cancer Immunology Research
|
March 3, 2021
Targeted Therapy Given after Anti-PD-1 Leads to Prolonged Responses in Mouse Melanoma Models through Sustained Antitumor Immunity
Manali S Phadke, Zhihua Chen, Jiannong Li, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 30, 2004
Efficacy and safety evaluation of human reovirus type 3 in immunocompetent animals: racine and nonhuman primates
Wen Qing Yang, Xueqing Lun, Cheryl Ann Palmer, et al.
Page
of 41
Search research articles
Search
Showing results (381-390 of 406) with videos related to
Sort By:
Page
of 41
Breast Cancer Research and Treatment
|
March 13, 2019
Clinical outcomes of breast leptomeningeal disease treated with intrathecal trastuzumab, intrathecal chemotherapy, or whole brain radiation therapy
Nicholas B Figura, Victoria T Rizk, Homan Mohammadi, et al.
International Journal of Molecular Sciences
|
May 7, 2025
Intravenous Immunoglobulin (IVIG) for Patients with Severe Neurotoxicity Associated with Chimeric Antigen Receptor T-Cell (CAR-T) Therapy
Sepideh Mokhtari, Justin M Asquith, Syeda Saba Kareem, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 26, 2021
Single-Cell Characterization of the Immune Microenvironment of Melanoma Brain and Leptomeningeal Metastases
Inna Smalley, Zhihua Chen, Manali Phadke, et al.
Neuro-Oncology
|
February 25, 2022
A preclinical model of patient-derived cerebrospinal fluid circulating tumor cells for experimental therapeutics in leptomeningeal disease from melanoma
Vincent Law, Zhihua Chen, Francesca Vena, et al.
Veterinary Pathology
|
May 5, 2006
The 2000 canine distemper epidemic in Caspian seals (Phoca caspica): pathology and analysis of contributory factors
T Kuiken, S Kennedy, T Barrett, et al.
BMC Cancer
|
May 16, 2021
Capecitabine and stereotactic radiation in the management of breast cancer brain metastases
Matthew N Mills, Afrin Naz, Chetna Thawani, et al.
Neuro-Oncology
|
April 16, 2013
Treating brain tumor-initiating cells using a combination of myxoma virus and rapamycin
Franz J Zemp, Xueqing Lun, Brienne A McKenzie, et al.
Cancer Immunology Research
|
November 17, 2021
Identification of Immunogenic MHC Class II Human HER3 Peptides that Mediate Anti-HER3 CD4<sup>+</sup> Th1 Responses and Potential Use as a Cancer Vaccine
Amrita Basu, Gabriella K Albert, Sabrina Awshah, et al.
Cancer Immunology Research
|
March 3, 2021
Targeted Therapy Given after Anti-PD-1 Leads to Prolonged Responses in Mouse Melanoma Models through Sustained Antitumor Immunity
Manali S Phadke, Zhihua Chen, Jiannong Li, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 30, 2004
Efficacy and safety evaluation of human reovirus type 3 in immunocompetent animals: racine and nonhuman primates
Wen Qing Yang, Xueqing Lun, Cheryl Ann Palmer, et al.
Page
of 41